Rachid Malek
Setif, Algeria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
A Summary of Cardiometabolic Disorders in the Maghreb: Insights from the 2025 Saclay Cardiometabolic Summit.
Journal: Cardiology and therapy
Published: February 16, 2026
Summary of Research: Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 04, 2025
Perspectives of type 2 diabetes mellitus management in Algeria: a comprehensive expert review.
Journal: Frontiers in clinical diabetes and healthcare
Published: September 13, 2024
An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022.
Journal: Current medical research and opinion
Published: July 30, 2024
Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: June 21, 2024
Integrated image-based deep learning and language models for primary diabetes care.
Journal: Nature medicine
Published: November 26, 2023
Assessing hand and global disability in a cohort of Algerian patients with systemic sclerosis: Construct validities of the Arab Hand Function Index and the Arabic Health Assessment Questionnaire.
Journal: Journal of scleroderma and related disorders
Published: November 02, 2023
Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: The DaR global survey.
Journal: Diabetes & metabolic syndrome
Published: December 30, 2022
Comparative efficacy and safety of Gla-300 versus IDegAsp in insulin-naïve people with type 2 diabetes mellitus uncontrolled on oral anti-diabetics.
Journal: Diabetes, obesity & metabolism
Published: December 22, 2022
Real-world Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Mellitus During the Period of Ramadan in Four Countries (Egypt, Jordan, Lebanon, and Turkey): A Prospective Observational Study.
Journal: Current diabetes reviews
Published: November 14, 2022
Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study.
Journal: Diabetes & metabolic syndrome
Published: October 20, 2022
Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort.
Journal: Frontiers in endocrinology
Published: May 10, 2022
Last Updated: 09/26/2026